Brivaracetam
9 NDCs across 1 manufacturer|0 Generic,9 Brand
Brivaracetam is used to treat seizures, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 12, 2016, and the first generic was approved Jun 9, 2022. FDA's Orange Book lists 37 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $220 million on Brivaracetam across 137,000 claims for 15,000 beneficiaries.
Brivaracetam is available as 9 NDCs from 1 manufacturer (0 generic, 9 brand), with NADAC prices from $23.99 to $24.08 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
9
0G / 9B
Manufacturers
1
competing in market
Price Spread
$23.99 – $24.08
per EA, 8 of 9 NDCs
7d Activity
avg +0.0% WoW · of 9 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing BRIVARACETAM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BRIVIACT 50 MG TABLET | $24.0795 per EA | 0.00% |
BRIVIACT 50 MG TABLET | $24.0795 per EA | 0.00% |
BRIVIACT 100 MG TABLET | $24.0762 per EA | +0.02% |
BRIVIACT 100 MG TABLET | $24.0762 per EA | +0.02% |
BRIVIACT 25 MG TABLET | $24.0660 per EA | 0.00% |
BRIVIACT 25 MG TABLET | $24.0660 per EA | 0.00% |
BRIVIACT 75 MG TABLET | $24.0487 per EA | -0.05% |
BRIVIACT 10 MG TABLET | $23.9864 per EA | +0.14% |
BRIVIACT 10 MG/ML ORAL SOLN | $4.8098 per ML | -0.01% |
Frequently Asked Questions
What is Brivaracetam used to treat?
Brivaracetam is used to treat seizures, per the National Library of Medicine's MED-RT classification.
When did Brivaracetam become available as a generic?
FDA approved the first generic Brivaracetam (ANDA) on Jun 9, 2022. The Orange Book currently lists 37 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Brivaracetam?
In 2024, Medicare Part D spent $220 million on Brivaracetam across 137,000 claims for 15,000 beneficiaries.
How many Brivaracetam products are on the market?
The Brivaracetam drug market contains 9 NDCs from 1 manufacturer — 0 generic and 9 brand products.
What is the price range for Brivaracetam?
NADAC reference prices for Brivaracetam range from $23.9864 to $24.0795 per EA — a 0% difference between cheapest and most expensive. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Which manufacturers make Brivaracetam?
1 manufacturer lists Brivaracetam in NADAC. Ranked by number of NDCs, the largest are UCB, Inc. (9).
How has the price of Brivaracetam changed recently?
Over the past 7 days, 3 Brivaracetam NDCs rose and 2 fell, with a market-wide average change of +0.0%.